House Republicans want FDA to expand the Parallel Track pathway, which currently provides patients with HIV and AIDS drugs that have not been FDA approved but are being studied in clinical trials, to include potential therapies for debilitating diseases such as Alzheimer’s and cancer. The lawmakers’ request echoes one made by a group of Republican senators in May . In a letter sent to FDA Acting Commissioner Ned Sharpless Thursday (July 11), 11 House Republicans say FDA’s Parallel Track program...